Sfoglia per Rivista JOURNAL FOR IMMUNOTHERAPY OF CANCER
First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma
2023-01-01 Strauss, Julius; Deville, Jean-Laurent; Sznol, Mario; Ravaud, Alain; Maruzzo, Marco; Pachynski, Russell K; Gourdin, Theodore S; Maio, Michele; Dirix, Luc; Schlom, Jeffrey; Donahue, Renee N; Tsai, Yo-Ting; Wang, Xiaozhe; Vugmeyster, Yulia; Beier, Frank; Seebeck, Joerg; Schroeder, Andreas; Chennoufi, Sarah; Gulley, James L
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817
2023-01-01 Ready, Neal E; Audigier-Valette, Clarisse; Goldman, Jonathan W; Felip, Enriqueta; Ciuleanu, Tudor-Eliade; Rosario García Campelo, María; Jao, Kevin; Barlesi, Fabrice; Bordenave, Stéphanie; Rijavec, Erika; Urban, Laszlo; Aucoin, Jean-Sébastien; Zannori, Cristina; Vermaelen, Karim; Arén Frontera, Osvaldo; Curioni Fontecedro, Alessandra; Sánchez-Gastaldo, Amparo; Juan-Vidal, Oscar; Linardou, Helena; Poddubskaya, Elena; Spigel, David R; Ahmed, Samreen; Maio, Michele; Li, Sunney; Chang, Han; Fiore, Joseph; Acevedo, Angelic; Paz-Ares, Luis
KEYNOTE-022 part 3: A randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma
2020-01-01 Ferrucci, P. F.; Di Giacomo, A. M.; Del Vecchio, M.; Atkinson, V.; Schmidt, H.; Schachter, J.; Queirolo, P.; Long, G. V.; Stephens, R.; Svane, I. M.; Lotem, M.; Abu-Amna, M.; Gasal, E.; Ghori, R.; Diede, S. J.; Croydon, E. S.; Ribas, A.; Ascierto, P. A.
Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases
2021-01-01 Minniti, G.; Lanzetta, G.; Capone, L.; Giraffa, M.; Russo, I.; Cicone, F.; Bozzao, A.; Alongi, F.; Nicosia, L.; Fineschi, G.; Marchetti, L.; Tufo, T.; Bianciardi, F.; Esposito, V.; Gentile, P.; Paolini, S.
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel
2022-01-01 Spada, Francesca; Bossi, Paolo; Caracò, Corrado; Sileni, Vanna Chiarion; Dei Tos, Angelo Paolo; Fazio, Nicola; Grignani, Giovanni; Maio, Michele; Quaglino, Pietro; Queirolo, Paola; Ascierto, Paolo Antonio; DELPHI Panel, Members; DI GIACOMO, ANNA MARIA
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
2020-01-01 Ascierto, P. A.; Del Vecchio, M.; Mackiewicz, A.; Robert, C.; Chiarion-Sileni, V.; Arance, A.; Lebbe, C.; Svane, I. M.; Mcneil, C.; Rutkowski, P.; Loquai, C.; Mortier, L.; Hamid, O.; Bastholt, L.; Dreno, B.; Schadendorf, D.; Garbe, C.; Nyakas, M.; Grob, J. -J.; Thomas, L.; Liszkay, G.; Smylie, M.; Hoeller, C.; Ferraresi, V.; Grange, F.; Gutzmer, R.; Pikiel, J.; Hosein, F.; Simsek, B.; Maio, M.
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: Evaluation of brain control and toxicity
2019-01-01 Minniti, G.; Anzellini, D.; Reverberi, C.; Cappellini, G. C. A.; Marchetti, L.; Bianciardi, F.; Bozzao, A.; Osti, M.; Gentile, P. C.; Esposito, V.
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia
2021-01-01 Caracciolo, D.; Riillo, C.; Ballerini, A.; Gaipa, G.; Lhermitte, L.; Rossi, M.; Botta, C.; Duroyon, E.; Grillone, K.; Cantafio, M. E. G.; Buracchi, C.; Alampi, G.; Gulino, A.; Belmonte, B.; Conforti, F.; Golino, G.; Juli, G.; Altomare, E.; Polera, N.; Scionti, F.; Arbitrio, M.; Iannone, M.; Martino, M.; Correale, P.; Talarico, G.; Di Rora, A. G. L.; Ferrari, A.; Concolino, D.; Sestito, S.; Pensabene, L.; Giordano, A.; Hildinger, M.; Di Martino, M. T.; Martinelli, G.; Tripodo, C.; Asnafi, V.; Biondi, A.; Tagliaferri, P.; Tassone, P.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma | 1-gen-2023 | Strauss, Julius; Deville, Jean-Laurent; Sznol, Mario; Ravaud, Alain; Maruzzo, Marco; Pachynski, Russell K; Gourdin, Theodore S; Maio, Michele; Dirix, Luc; Schlom, Jeffrey; Donahue, Renee N; Tsai, Yo-Ting; Wang, Xiaozhe; Vugmeyster, Yulia; Beier, Frank; Seebeck, Joerg; Schroeder, Andreas; Chennoufi, Sarah; Gulley, James L | - | |
| First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817 | 1-gen-2023 | Ready, Neal E; Audigier-Valette, Clarisse; Goldman, Jonathan W; Felip, Enriqueta; Ciuleanu, Tudor-Eliade; Rosario García Campelo, María; Jao, Kevin; Barlesi, Fabrice; Bordenave, Stéphanie; Rijavec, Erika; Urban, Laszlo; Aucoin, Jean-Sébastien; Zannori, Cristina; Vermaelen, Karim; Arén Frontera, Osvaldo; Curioni Fontecedro, Alessandra; Sánchez-Gastaldo, Amparo; Juan-Vidal, Oscar; Linardou, Helena; Poddubskaya, Elena; Spigel, David R; Ahmed, Samreen; Maio, Michele; Li, Sunney; Chang, Han; Fiore, Joseph; Acevedo, Angelic; Paz-Ares, Luis | - | |
| KEYNOTE-022 part 3: A randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma | 1-gen-2020 | Ferrucci, P. F.; Di Giacomo, A. M.; Del Vecchio, M.; Atkinson, V.; Schmidt, H.; Schachter, J.; Queirolo, P.; Long, G. V.; Stephens, R.; Svane, I. M.; Lotem, M.; Abu-Amna, M.; Gasal, E.; Ghori, R.; Diede, S. J.; Croydon, E. S.; Ribas, A.; Ascierto, P. A. | - | |
| Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases | 1-gen-2021 | Minniti, G.; Lanzetta, G.; Capone, L.; Giraffa, M.; Russo, I.; Cicone, F.; Bozzao, A.; Alongi, F.; Nicosia, L.; Fineschi, G.; Marchetti, L.; Tufo, T.; Bianciardi, F.; Esposito, V.; Gentile, P.; Paolini, S. | - | |
| Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel | 1-gen-2022 | Spada, Francesca; Bossi, Paolo; Caracò, Corrado; Sileni, Vanna Chiarion; Dei Tos, Angelo Paolo; Fazio, Nicola; Grignani, Giovanni; Maio, Michele; Quaglino, Pietro; Queirolo, Paola; Ascierto, Paolo Antonio; DELPHI Panel, Members; DI GIACOMO, ANNA MARIA | - | |
| Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma | 1-gen-2020 | Ascierto, P. A.; Del Vecchio, M.; Mackiewicz, A.; Robert, C.; Chiarion-Sileni, V.; Arance, A.; Lebbe, C.; Svane, I. M.; Mcneil, C.; Rutkowski, P.; Loquai, C.; Mortier, L.; Hamid, O.; Bastholt, L.; Dreno, B.; Schadendorf, D.; Garbe, C.; Nyakas, M.; Grob, J. -J.; Thomas, L.; Liszkay, G.; Smylie, M.; Hoeller, C.; Ferraresi, V.; Grange, F.; Gutzmer, R.; Pikiel, J.; Hosein, F.; Simsek, B.; Maio, M. | - | |
| Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: Evaluation of brain control and toxicity | 1-gen-2019 | Minniti, G.; Anzellini, D.; Reverberi, C.; Cappellini, G. C. A.; Marchetti, L.; Bianciardi, F.; Bozzao, A.; Osti, M.; Gentile, P. C.; Esposito, V. | - | |
| Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia | 1-gen-2021 | Caracciolo, D.; Riillo, C.; Ballerini, A.; Gaipa, G.; Lhermitte, L.; Rossi, M.; Botta, C.; Duroyon, E.; Grillone, K.; Cantafio, M. E. G.; Buracchi, C.; Alampi, G.; Gulino, A.; Belmonte, B.; Conforti, F.; Golino, G.; Juli, G.; Altomare, E.; Polera, N.; Scionti, F.; Arbitrio, M.; Iannone, M.; Martino, M.; Correale, P.; Talarico, G.; Di Rora, A. G. L.; Ferrari, A.; Concolino, D.; Sestito, S.; Pensabene, L.; Giordano, A.; Hildinger, M.; Di Martino, M. T.; Martinelli, G.; Tripodo, C.; Asnafi, V.; Biondi, A.; Tagliaferri, P.; Tassone, P. | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile